恒瑞、百济双雄挺进TOP20!翰森、博泰加速冲刺,11家中国药企入榜,药企市值TOP50大洗牌

E药经理人
Jan 04

资本市场买不买单,不再取决于故事讲得是否动听。撰文| Kathy当2025年11月21日,礼来市值突破了1万亿美元大关,成为全球首家跻身“万亿俱乐部”的制药公司,几乎标志了全球医药资本市场的竞争逻辑发生了根本性转变。2025年的全球药企市值TOP50榜单,不再是跨国巨头的独角戏,11家中国药企集体亮剑。中国药企的集体突围,既见证了礼来式 “超级单品” 拉动市值的极致效应,更印证了中国创新药两条路径...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10